Down-regulated miR-148b increases resistance to CHOP in diffuse large B-cell lymphoma cells by rescuing Ezrin

MiR-148a Attenuates Paclitaxel Resistance of Hormone-refractory, Drug-resistant Prostate Cancer PC3 Cells by Regulating MSK1 Expression

Yasunori Fujita, Keitaro Kojima, Riyako Ohhashi et al. · Journal of Biological Chemistry · 2010 · 196 citations · Full text

Medicine, Molecular Biology, Oncology +16

HDAC6 promotes cell proliferation and confers resistance to temozolomide in glioblastoma

Zhihao Wang, Pengchao Hu, Fang Tang et al. · Cancer Letters · 2016 · 114 citations

Medicine, Oncology, Pharmacology +12

Dual Targeting of Protein Degradation Pathways with the Selective HDAC6 Inhibitor ACY-1215 and Bortezomib Is Synergistic in Lymphoma

Jennifer E. Amengual, Paul Johannet, Maximilian Lombardo et al. · Clinical Cancer Research · 2015 · 91 citations

Medicine, Oncology, Pharmacology +14

Mir-148a Improves Response to Chemotherapy in Sensitive and Resistant Oesophageal Adenocarcinoma and Squamous Cell Carcinoma Cells

Richard Hummel, David I. Watson, Cameron Smith et al. · Journal of Gastrointestinal Surgery · 2011 · 90 citations

Medicine, Molecular Medicine, Oncology +14

MiR-205-5p and miR-342-3p cooperate in the repression of the E2F1 transcription factor in the context of anticancer chemotherapy resistance

Xin Lai, Shailendra K. Gupta, Ulf Schmitz et al. · Theranostics · 2018 · 78 citations · Full text

Medicine, Molecular Biology, Oncology +17